Brief: Chimeric Therapeutics Says It Entered Manufacturing Partnership With Wuxi ATU
12/04/2022 02:30
April 12 (Reuters) - Chimeric Therapeutics Ltd CHM.AX :
* ENTERED INTO A STRATEGIC MANUFACTURING PARTNERSHIP WITH
WUXI ATU
* UNDER DEAL, CHIMERIC WILL TRANSFER CERTAIN MANUFACTURING
AND
ANALYTICAL TESTING TECHNOLOGIES TO WUXI ATU
Source text for Eikon: ID:nASX8QFMBb
Further company coverage: CHM.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Chimeric Therapeutics
See all newsBrief: Chimeric Therapeutics Says Phillip Hains Appointed Interim Chairman
Brief: Chimeric Therapeutics Posts Prelim Loss For Year Of A$18.8 MLN
Brief: Chimeric Therapeutics Intends To Enter Negotiations With Its Creditors
Brief: Chimeric Therapeutics Seeks Trading Halt
Australia's Chimeric Therapeutics rises on positive data for its cell therapy clinical trial